Jordan - engleski - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية الصباغ - sabbagh drug store - calcium folinate corresponding to 15mg folinic acid - corresponding to 15mg folinic acid

Australija - engleski - Department of Health (Therapeutic Goods Administration)

resmed pty ltd - 61444 - respiratory thermal shield - respiratory thermal shield

Europska Unija - engleski - EMA (European Medicines Agency)

dompé biotec s.p.a. - darbepoetin alfa - kidney failure, chronic; anemia; cancer - antianemic preparations - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adults and paediatric patients.treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

daily spf pty ltd trading as beauti-fltr - zinc oxide, quantity: 227.5 mg/g - cream - excipient ingredients: isostearic acid; polyglyceryl-3 polyricinoleate; medium chain triglycerides; sodium benzoate; cetostearyl alcohol; disodium edetate; glycerol; octyldodecanol; purified water; gluconolactone; sodium chloride; cetearyl glucoside; peg-30 dipolyhydroxystearate; xanthan gum; terminalia ferdinandiana; d-alpha-tocopheryl acetate; mica; iron oxide red; iron oxide yellow; titanium dioxide; coco-octanoate/decanoate - spf 50 plus broad spectrum very high protection sunscreen

Izrael - engleski - Ministry of Health

rafa laboratories ltd - roflumilast - film coated tablets - roflumilast 500 mcg - roflumilast - roflumilast - maintenance treatment of severe chronic obstructive pulmonary disease (copd) (fev1 post-bronchodilator less than 50% predicted) associated with chronic bronchitis in adult patients with a history of frequent exacerbations as add on to bronchodilator treatment..

Izrael - engleski - Ministry of Health

abic marketing ltd, israel - budesonide micronized; formoterol fumarate dihydrate - powder for inhalation - formoterol fumarate dihydrate 4.5 mcg/dose; budesonide micronized 160 mcg/dose - formoterol and budesonide - asthmaduoresp spiromax 160/4.5 mcg/dose is indicated in adults and adolescents (12 years and older), for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long acting β2 adrenoceptor agonist) is appropriate:patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short acting β2 adrenoceptor agonists.orpatients already adequately controlled on both inhaled corticosteroids and long acting β2 adrenoceptor-agonists.chronic obstructive pulmonary disease (copd)duoresp spiromax 160/4.5 mcg/dose is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev1)< 70% predicted normal (post-bronchodilator) and an exacerbation history despite regular bronchodilator therapy

Australija - engleski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

laboratoire veterinaire audevard sa - hesperidin methyl chalcone - active constituent

Malezija - engleski - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

esprit care sdn. bhd. - squalene; ovine placenta extract; grape seed oil -

Malezija - engleski - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

esprit care sdn. bhd. - lutein; mixed carotenoids; zeaxanthin; vitis vinifera (grape seed extract); vaccinium myrtillus fruit extract (bilberry) -

Australija - engleski - Department of Health (Therapeutic Goods Administration)

actegy pty ltd - 43017 - respiratory muscle training mask - the device is intended to produce beneficial effects in terms of increased respiratory fitness in healthy humans and in patients with cystic fibrosis, copd, and asthma; reduce breathlessness in healthy humans and patients with asthma and copd; improve sputum clearance in patients with cystic fibrosis and bronchiectasis; and improve quality of life in patients with copd, bronchiectasis, asthma and cystic fibrosis.